flr-20250331

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 1-16129

FLUOR CORPORATION

(Exact name of registrant as specified in its charter)


Delaware		33-0927079
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

6700 Las Colinas Boulevard
Irving,	Texas	75039
(Address of principal executive offices)		(Zip Code)

469-398-7000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Stock, $.01 par value per share	FLR	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ý No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of April 30, 2025, 164,664,708 shares of the registrant’s common stock, $0.01 par value, were outstanding.

Table of Contents

FLUOR CORPORATION

FORM 10-Q


TABLE OF CONTENTS			PAGE

	Glossary of Terms		2

Part I:	Financial Information
	Item 1:	Condensed Consolidated Financial Statements (Unaudited)
		Statement of Operations	3
		Statement of Comprehensive Income	4
		Balance Sheet	5
		Statement of Cash Flows	6
		Statement of Changes in Equity	7
		Notes to Financial Statements	8
	Item 2:	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
	Item 3:	Quantitative and Qualitative Disclosures about Market Risk	20
	Item 4:	Controls and Procedures	20
	Changes in Consolidated Backlog (Unaudited)		22

Part II:	Other Information
	Item 1:	Legal Proceedings	23
	Item 1A:	Risk Factors	23
	Item 2:	Unregistered Sales of Equity Securities and Use of Proceeds	23
	Item 4:	Mine Safety Disclosures	23
	Item 5:	Other Information	23
	Item 6:	Exhibits	24

Signatures			25

Table of Contents

Glossary of Terms

The abbreviations and definitions set forth below apply to the Fluor-specific terms used throughout this filing.


Abbreviation/Term			Definition
Fluor			Fluor Corporation
NuScale			NuScale Power Corporation
SGI			Stock growth incentive awards
Stork			Stork Holding B.V. and subsidiaries

The abbreviations and definitions set forth below apply to the indicated terms used throughout this filing.


Abbreviation/Term			Definition
2024 10-K			Annual Report on Form 10-K for the year ended December 31, 2024
2024 Quarter			Three months ended March 31, 2024
2025 Quarter			Three months ended March 31, 2025
3ME			Three months ended
AOCI			Accumulated other comprehensive income (loss)
APIC			Additional paid-in capital
ASC			Accounting Standards Codification
ASU			Accounting Standards Update
CFM			Customer-furnished materials
CTA			Currency translation adjustment
DOE			U.S. Department of Energy
EPC			Engineering, procurement and construction
EPS			Earnings (loss) per share
Exchange Act			Securities Exchange Act of 1934
FASB			Financial Accounting Standards Board
G&A			General and administrative expense
GAAP			Accounting principles generally accepted in the United States
ICFR			Internal control over financial reporting
IT			Information technology
NCI			Noncontrolling interests
NM			Not meaningful
OCI			Other comprehensive income (loss)
PP&E			Property, plant and equipment
RSU			Restricted stock units
RUPO			Remaining unsatisfied performance obligations
SEC			Securities and Exchange Commission
TSR			Total shareholder return
VIE			Variable interest entity

Table of Contents

PART I: FINANCIAL INFORMATION

Item 1. Financial Statements

FLUOR CORPORATION

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

UNAUDITED


	3ME March 31,
(in millions, except per share amounts)	2025		2024
Revenue	$	3,982	$	3,734
Cost of revenue	(3,842)		(3,635)
Gross profit	140		99
G&A	(36)		(59)
Foreign currency gain (loss)	(13)		12
Operating profit	91		52
Interest expense	(12)		(13)
Interest income	29		52
Earnings before taxes	108		91
Income tax benefit (expense) (including $73 million tax benefit attributable to equity method loss in 2025)	53		(51)
Net earnings before equity method earnings	161		40
Equity method earnings (loss)	(393)		—
Net earnings (loss)	(232)		40
Less: Net earnings (loss) attributable to NCI	9		(19)
Net earnings (loss) attributable to Fluor	$	(241)	$	59

Basic EPS	$	(1.42)	$	0.35
Diluted EPS	$	(1.42)	$	0.34

The accompanying notes are an integral part of these financial statements.

Table of Contents

FLUOR CORPORATION

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)

UNAUDITED


	3ME March 31,
(in millions)	2025		2024
Net earnings (loss)	$	(232)	$	40

OCI, net of tax:
Foreign currency translation adjustment	26		(45)

Other	—		(5)
Total OCI, net of tax	26		(50)
Comprehensive income (loss)	(206)		(10)
Less: Comprehensive income (loss) attributable to NCI	9		(19)
Comprehensive income (loss) attributable to Fluor	$	(215)	$	9

The accompanying notes are an integral part of these financial statements.

Table of Contents

FLUOR CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEET

UNAUDITED


(in millions, except share and per share amounts)	March 31, 2025		December 31, 2024
ASSETS
Current assets
Cash and cash equivalents ($325 and $333 related to VIEs)	$	2,433	$	2,829
Marketable securities ($68 and $59 related to VIEs)	78		130
Accounts receivable, net ($89 and $92 related to VIEs)	918		921
Contract assets ($148 and $130 related to VIEs)	1,310		1,138
Other current assets ($35 and $32 related to VIEs)	172		157
Total current assets	4,911		5,175
Noncurrent assets
PP&E, net ($44 and $46 related to VIEs)	480		494
Investments	2,376		2,828
Other assets ($16 and $17 related to VIEs)	656		646
Total noncurrent assets	3,512		3,968
Total assets	$	8,423	$	9,143
LIABILITIES AND EQUITY
Current liabilities
Accounts payable ($254 and $233 related to VIEs)	$	1,323	$	1,220
Contract liabilities ($233 and $278 related to VIEs)	580		684
Accrued salaries, wages and benefits ($17 and $18 related to VIEs)	516		640
Other accrued liabilities ($43 and $37 related to VIEs)	400		527
Total current liabilities	2,819		3,071

Long-term debt	1,087		1,104
Deferred taxes	412		468
Other noncurrent liabilities	455		508

Commitments and contingencies

Equity
Shareholders’ equity
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 166,159,352 and 169,228,759 shares in 2025 and 2024, respectively	2		2
APIC	1,031		1,174
AOCI	(325)		(351)
Retained earnings	2,883		3,124
Total shareholders’ equity	3,591		3,949
NCI	59		43
Total equity	3,650		3,992
Total liabilities and equity	$	8,423	$	9,143

The accompanying notes are an integral part of these financial statements.

Table of Contents

FLUOR CORPORATION

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

UNAUDITED


	3ME March 31,
(in millions)	2025		2024
OPERATING CASH FLOW
Net earnings (loss)	$	(232)	$	40
Adjustments to reconcile net earnings (loss) to operating cash flow:
Equity method (earnings) loss	393		—
Depreciation and amortization	18		18
Gain on sales of assets	(8)		(11)
Stock-based compensation	12		13
Deferred taxes	(80)		17
Changes in assets and liabilities	(384)		(190)
Other	(5)		2
Operating cash flow	(286)		(111)

INVESTING CASH FLOW
Purchases of marketable securities	(21)		(49)
Proceeds from sales and maturities of marketable securities	75		44
Capital expenditures	(11)		(34)
Proceeds from sales of assets	62		30
Investments in partnerships and joint ventures	(69)		(13)

Investing cash flow	36		(22)

FINANCING CASH FLOW
Repurchase of common stock	(142)		—
Purchase and retirement of debt	(18)		(10)
Other	(3)		(16)
Financing cash flow	(163)		(26)

Effect of exchange rate changes on cash	17		(25)
Decrease in cash and cash equivalents	(396)		(184)
Cash and cash equivalents at beginning of period	2,829		2,519
Cash and cash equivalents at end of period	$	2,433	$	2,335

SUPPLEMENTAL INFORMATION:
Cash paid for interest	$	19	$	20
Cash paid for income taxes (net of refunds)	30		46

The accompanying notes are an integral part of these financial statements.

Table of Contents

FLUOR CORPORATION

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

UNAUDITED


(in millions, except per share amounts)	Common Stock			APIC		AOCI		Retained Earnings		Total Shareholders' Equity		NCI		Total Equity
	Shares	Amount
BALANCE AS OF DECEMBER, 2024	169	$	2	$	1,174	$	(351)	$	3,124	$	3,949	$	43	$	3,992
Net earnings (loss)	—	—		—		—		(241)		(241)		9		(232)
OCI	—	—		—		26		—		26		—		26
Distributions to NCI, net of contributions	—	—		—		—		—		—		8		8
Other NCI transactions	—	—		—		—		—		—		(1)		(1)
Stock-based plan activity	1	—		1		—		—		1		—		1
Repurchase of common stock	(4)	—		(144)		—		—		(144)		—		(144)
BALANCE AS OF MARCH 31, 2025	166	$	2	$	1,031	$	(325)	$	2,883	$	3,591	$	59	$	3,650


(in millions, except per share amounts)	Common Stock			APIC		AOCI		Retained Earnings		Total Shareholders' Equity		NCI		Total Equity
	Shares	Amount
BALANCE AS OF DECEMBER 31, 2023	170	$	2	$	1,228	$	(269)	$	979	$	1,940	$	112	$	2,052
Net earnings (loss)	—	—		—		—		59		59		(19)		40
OCI	—	—		—		(50)		—		(50)		—		(50)
Distributions to NCI, net of contributions	—	—		—		—		—		—		(2)		(2)
Other NCI transactions	—	—		3		—		—		3		2		5
Stock-based plan activity	1	—		(1)		—		—		(1)		—		(1)
BALANCE AS OF MARCH 31, 2024	171	$	2	$	1,230	$	(319)	$	1,038	$	1,951	$	93	$	2,044

The accompanying notes are an integral part of these financial statements.

Table of Contents

FLUOR CORPORATION

NOTES TO FINANCIAL STATEMENTS

UNAUDITED

1. Principles of Consolidation

These financial statements do not include footnotes and certain financial information presented annually under GAAP, and therefore, should be read in conjunction with our 2024 10-K. Accounting measurements at interim dates inherently involve greater reliance on estimates than at year-end. Although such estimates are based on management’s most recent assessment of the underlying facts and circumstances utilizing the most current information available, our reported results of operations may not necessarily be indicative of results that we expect for the full year.

The financial statements included herein are unaudited. We believe they contain all adjustments of a normal recurring nature which are necessary to fairly present our financial position and our operating results as of and for the periods presented. All significant intercompany transactions of consolidated subsidiaries are eliminated. Certain amounts in tables may not total or agree back to the financial statements due to immaterial rounding differences. We have evaluated all material events occurring subsequent to March 31, 2025 through the filing date of this 10-Q.

Quarters are typically 13 weeks in length but, due to our December 31 year-end, the number of weeks in a reporting period may vary slightly during the year and for comparable prior year periods. We report our quarterly results of operations based on periods ending on the Sunday nearest March 31, June 30 and September 30, allowing for 13-week interim reporting periods. For clarity of presentation, all periods are labeled as if the periods ended on March 31, June 30 and September 30.

2. Recent Accounting Pronouncements

In 2025, we adopted ASU 2023-05, which requires certain joint ventures to apply a new basis of accounting upon formation by recognizing and initially measuring most of their assets and liabilities at fair value. The guidance does not apply to joint ventures that may be proportionately consolidated and those that are collaborative arrangements. The adoption did not have any impact on our consolidated results.

During 2023, the FASB issued ASU 2023-09, which requires us to disclose income taxes paid, net of refunds, disaggregated by federal, state and foreign taxes and to provide more details in our rate reconciliation about items that meet a quantitative threshold. ASU 2023-09 is effective for annual reporting beginning in 2025. We are currently evaluating the impact this ASU will have on our financial statements, but do not expect it to have any impact to our consolidated results.

During 2024, the FASB issued ASU 2024-03 on the disaggregation of income statement expenses or "DISE." This ASU requires additional footnote disclosure of the details of certain income statement expense line items, without changing amounts reported on the consolidated income statement. ASU 2024-03 is first effective for our annual reporting for 2027 and for our quarterly reporting beginning in 2028. We do not expect this ASU to have any impact on our consolidated results.

In October 2024, the FASB issued a proposed ASU to make targeted improvements to the guidance on internal use software to address specific issues raised by stakeholders. The proposed ASU will require entities to use judgment in evaluating when to recognize software costs. A final ASU is expected to be issued in 2025.

Table of Contents

FLUOR CORPORATION

NOTES TO FINANCIAL STATEMENTS

UNAUDITED

3. Earnings Per Share

Potentially dilutive securities include convertible debt, stock options, RSUs and performance-based award units. Diluted EPS reflects the assumed exercise or conversion of all dilutive securities using the if-converted and treasury stock methods. In computing diluted EPS, only securities that are actually dilutive are included.


	3ME March 31,
(in millions, except per share amounts)	2025		2024
Net earnings (loss) attributable to Fluor	$	(241)	$	59

Weighted average common shares outstanding	169		171
Diluted effect:
Stock options, RSUs and performance-based award units	—		2
Convertible debt (1)	—		—
Weighted average diluted shares outstanding	169		173

Basic EPS	$	(1.42)	$	0.35
Diluted EPS	$	(1.42)	$	0.34

Anti-dilutive securities not included in shares outstanding:
Stock options, RSUs and performance-based award units	3		2

(1) Holders of our 2029 Notes may convert their notes at a conversion price of $45.37 per share when the stock price exceeds $58.98 for 20 of the last 30 days preceding quarter end. Upon conversion, we will repay the principal amount of the notes in cash and may elect to convey the conversion premium in cash, shares of our common stock or a combination of both. The conversion feature of our 2029 Notes has a dilutive impact on EPS when the average market price of our common stock exceeds the conversion price of $45.37 per share for the quarter. During the 2025 and 2024 Quarters, the weighted average price of our common stock was below the minimum conversion price.

Table of Contents

FLUOR CORPORATION

NOTES TO FINANCIAL STATEMENTS

UNAUDITED

4. Operating Information by Segment and Geographic Area


	3ME March 31,
(in millions)	2025		2024
Revenue
Urban Solutions	$	2,157	$	1,479
Energy Solutions	1,206		1,432
Mission Solutions	597		601
Other	22		222
Total revenue	$	3,982	$	3,734

Cost of revenue
Urban Solutions	$	(2,081)	$	(1,427)
Energy Solutions	(1,158)		(1,363)
Mission Solutions	(590)		(575)
Other	(13)		(270)
Total cost of revenue	$	(3,842)	$	(3,635)

Segment profit (loss)
Urban Solutions	$	70	$	50
Energy Solutions	47		68
Mission Solutions	5		22
Other	9		(22)
Total segment profit	$	131	$	118

G&A	(36)		(59)
Foreign currency gain (loss)	(13)		12
Interest income (expense), net	17		39
Earnings (loss) attributable to NCI	9		(19)
Earnings before taxes	$	108	$	91

Intercompany revenue for our professional staffing business, excluded from revenue above	$	58	$	81

Urban Solutions. Segment profit increased in the 2025 Quarter due to an increase in execution activities on life sciences projects awarded in the last 18 months and a large metals project as well as a decrease in cost due to design optimization on a highway project. We also recognized profit on a metals project upon a change in percentage of completion due to a change in scope. The increase in segment profit was partially offset by the effects of unfavorable foreign currency movements on an international bridge project.

Energy Solutions. Segment profit declined during the 2025 Quarter due to projects nearing completion and the impact of reserves taken for a joint venture project in Mexico completed in 2019, partially offset by profit recognition on a chemicals project upon a change in percentage of completion due to a client directed change in scope. Segment profit in the 2024 Quarter was adversely impacted by $29 million (or $0.12 per share) in cost growth on a construction only subcontract executed by our joint venture in Mexico.

Mission Solutions. Segment profit declined during the 2025 Quarter compared to the 2024 Quarter due to an additional reserve of $28 million (or $0.16 per share) resulting from a recent ruling on a long-standing claim on a project completed in 2019 partially offset by volume-related growth on a DOE project.

Table of Contents

FLUOR CORPORATION

NOTES TO FINANCIAL STATEMENTS

UNAUDITED

Other. Other included the operations of NuScale prior to deconsolidation in the fourth quarter of 2024 and the operations of the Stork businesses prior to their sale. In the 2025 Quarter, we completed the sale of Stork's operations in the U.K. and recognized a gain on sale of $7 million compared to an $11 million gain on the sale of Stork's operations in continental Europe in the 2024 Quarter. We expect results from our Other segment to be immaterial for 2025.

Total assets by segment are as follows:


(in millions)	March 31, 2025		December 31, 2024
Urban Solutions	$	1,661	$	1,472
Energy Solutions	735		729
Mission Solutions	784		734
Other	1,795		2,338
Corporate	3,448		3,870
Total assets	$	8,423	$	9,143

Revenue by project location follows:


	3ME March 31,
(in millions)	2025		2024
North America	$	2,653	$	2,372
Asia Pacific (includes Australia)	316		443
Europe	842		772
Central and South America	139		67
Middle East and Africa	32		80
Total revenue	$	3,982	$	3,734

5. Income Taxes

The effective tax rate on earnings for the 2025 Quarter was (49)% compared to 56% for the 2024 Quarter. A reconciliation of U.S. statutory federal income tax expense to income tax expense follows:


	3ME March 31,
(In millions)	2025		2024
U.S statutory federal income tax (benefit) expense	(60)		$	19
Increase (decrease) in taxes resulting from:
State and local income taxes, net of federal income tax effects	(7)		1
Valuation allowance, net	2		(4)
Foreign tax impacts	7		7
Noncontrolling interest	(2)		4
Reserve for uncertain tax positions	(3)		17
Other adjustments	10		7
Total income tax (benefit) expense	$	(53)	$	51

Table of Contents

FLUOR CORPORATION

NOTES TO FINANCIAL STATEMENTS

UNAUDITED

6. Partnerships and Joint Ventures

Many of our partnership and joint venture agreements provide for capital calls to fund operations, as necessary. Investments in a loss position of $206 million and $292 million were included in other accrued liabilities as of March 31, 2025 and December 31, 2024, respectively, and consisted primarily of provision for anticipated losses on 2 legacy infrastructure projects. Accounts receivable related to work performed for unconsolidated partnerships and joint ventures included in “Accounts receivable, net” was $192 million and $175 million as of March 31, 2025 and December 31, 2024, respectively.

Variable Interest Entities

The aggregate carrying value of unconsolidated VIEs (classified under both "Investments” and “Other accrued liabilities”) was a net asset of $2.0 billion and $2.4 billion as of March 31, 2025 and December 31, 2024, respectively. Some of our VIEs have debt; however, such debt is typically non-recourse to us. Our maximum exposure to loss as a result of our investments in unconsolidated VIEs is typically limited to the aggregate of the carrying value of the investment and future funding necessary to satisfy the contractual obligations of the VIE. Future funding commitments as of March 31, 2025 for the unconsolidated VIEs were $48 million.

We are required to consolidate certain VIEs. Assets and liabilities associated with the operations of our consolidated VIEs are presented on the balance sheet. The assets of a VIE are restricted for use only for the particular VIE and are not available for our general operations. We have agreements with certain VIEs to provide financial or performance assurances to clients, as discussed elsewhere.

7. Guarantees

The maximum potential amount of future payments that we could be required to make under outstanding performance guarantees, which represents the remaining cost of work to be performed, was estimated to be $15 billion as of March 31, 2025. For cost reimbursable contracts, amounts that may become payable pursuant to guarantee provisions are normally recoverable from the client for work performed. For lump-sum contracts, the performance guarantee amount is the cost to complete the contracted work, less amounts remaining to be billed to the client under the contract. Remaining billable amounts could be greater or less than the cost to complete. In those cases where costs exceed the remaining amounts payable under the contract, we may have recourse to third parties, such as owners, partners, subcontractors or vendors for claims. The performance guarantee obligation was not material as of March 31, 2025 and December 31, 2024.

8. Contingencies and Commitments

We and certain of our subsidiaries are subject to litigation, claims and other commitments and contingencies, including matters arising in the ordinary course of business, of which the asserted value may be significant. We record accruals in the financial statements for contingencies when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While there is at least a reasonable possibility that other losses may be incurred in excess of amounts accrued, management is unable to estimate the possible loss or range of loss or has determined such amounts to be immaterial, except as otherwise noted below. At present, except as set forth below, we do not expect that the ultimate resolution of any open matters will have a material adverse effect on our financial position or results of operations. However, legal proceedings and regulatory and governmental matters are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable outcomes could involve substantial monetary damages, fines, penalties and other expenditures. An unfavorable outcome might result in a material adverse impact on our business, results of operations or financial position. We might also enter into an agreement to settle one or more such matters if we determine such settlement is in the best interests of our stakeholders, and any such settlement could include substantial payments.

The following disclosures for commitments and contingencies have been updated since the matter was presented in the 2024 10-K.

Fluor Enterprises, Inc., our wholly-owned subsidiary, (“Fluor”) in conjunction with a partner, Balfour Beatty Infrastructure, Inc., (“Balfour”) formed a joint venture known as Prairie Link Constructors JV (“PLC”) and, through it, contracted with the North Texas Tollway Authority (“NTTA”) to provide design and build services for an extension of the NTTA’s President George Bush Turnpike highway (“Project”), which was completed in 2012. In October 2022, the NTTA served PLC, Fluor and Balfour with a petition, filed at Dallas County Court, demanding damages of an unquantified amount under various claims relating to alleged breaches of contract in relation to retaining walls along the Project. In November 2024, the

Table of Contents

FLUOR CORPORATION

NOTES TO FINANCIAL STATEMENTS

UNAUDITED

jury issued a $280 million verdict in favor of NTTA. In March 2025, the court issued a final judgment, awarding NTTA $280 million plus interest of $133 million and legal costs, thereby totaling approximately $415 million. The designs in question were performed by subcontractors to PLC, and these subcontractors owe contractual duties to defend and indemnify PLC from liability arising from their work. In April 2025, following a multi-party mediation, a settlement in principle was reached resolving NTTA’s claims against PLC and PLC’s claims against several of its subcontractors in relation to the Project, the terms of which are being finalized. Taking into account expected contributions by PLC’s subcontractors, Balfour and insurers, we recognized an $84 million impact to earnings to reduce the net liability to the ultimate settlement amount, inclusive of expected insurance proceeds.

There have been no substantive changes to the disclosures for the following commitments and contingencies since the matter was presented in the 2024 10-K.

Fluor Australia Ltd., our wholly-owned subsidiary (“Fluor Australia”), completed a cost reimbursable engineering, procurement and construction management services project for Santos Ltd. (“Santos”) involving a large network of natural gas gathering and processing facilities in Queensland, Australia. On December 13, 2016, Santos filed an action in Queensland Supreme Court (the “Court”) against Fluor Australia, asserting various causes of action and seeking damages and/or a refund of contract proceeds paid of AUD $1.47 billion. Santos has joined Fluor to the matter on the basis of a parent company guarantee issued for the project. In March 2023, a panel of 3 referees appointed by the Court (the "Panel”) issued a draft, non-binding report setting forth recommendations to the Court regarding liability and damages in the lawsuit. After consideration of further submissions by the parties, the Panel finalized its report on July 14, 2023. The Panel’s report has no legal effect unless it is adopted by the Court through an adoption hearing, and the Court can accept or reject, in whole or in part, the Panel’s recommendations. In the final report, the Panel recommended judgment for Fluor on one of Santos’s damages claims that Santos contends has an approximate value of AUD $700 million, and recommended judgment for Santos on other claims that the Panel valued at approximately AUD $790 million excluding interest and costs. While the project contract contains a liability cap of approximately AUD $236 million, the Panel found that the liability cap did not apply to Santos’s claims. Fluor has made an application to have the Court set aside the reference to the Panel and the Panel’s recommendations on several procedural and substantive grounds, including in relation to apparent bias of the referees, a failure to comply with the order which established the reference to the Panel and a lack of procedural fairness. In July 2023, the Court held oral argument on that application and reserved its decision. Pursuant to an application by Santos to adopt the Panel’s report, the Court then held an adoption hearing in February and March 2024 at which Fluor contended that the Court should not adopt the Panel’s recommendation based on numerous grounds, including the Panel’s failure to apply the project’s liability cap. The Court also reserved its decision at the close of the adoption hearing. We await the Court’s decisions on Fluor’s application to set aside the reference and Santos’s application to adopt the Panel’s report.

9. Contract Assets and Liabilities

The following summarizes information about our contract assets and liabilities:


(in millions)	March 31, 2025		December 31, 2024
Information about contract assets:
Contract assets
Unbilled receivables - reimbursable contracts	$	1,265	$	1,050
Contract work in progress - lump-sum contracts	45		88


Contract assets	$	1,310	$	1,138

	3ME March 31,
(in millions)	2025		2024
Information about contract liabilities:
Revenue recognized that was included in contract liabilities as of January 1	$	367	$	278

Table of Contents

FLUOR CORPORATION

NOTES TO FINANCIAL STATEMENTS

UNAUDITED

We periodically evaluate our project forecasts and the amounts recognized with respect to claims. We include estimated amounts for claims in project revenue to the extent it is probable we will realize those amounts. As of March 31, 2025 and December 31, 2024, we had recorded $230 million and $244 million, respectively, of revenue associated with claims for costs incurred to date. Additional costs, which will increase this balance over time, are expected to be incurred in future periods. We had up to $29 million and $23 million of back charges that may be disputed as of March 31, 2025 and December 31, 2024, respectively.

10. Remaining Unsatisfied Performance Obligations

We estimate that our RUPO will be satisfied over the following periods:


(in millions)	March 31, 2025
Within 1 year	$	15,166
1 to 2 years	7,062
Thereafter	4,993
Total RUPO	$	27,221

11. Debt and Letters of Credit

Debt consisted of the following:


(in millions)	March 31, 2025		December 31, 2024
Borrowings under credit facility	$	—	$	—

Senior Notes
2028 Notes (4.250% Senior Notes)	525		543
Unamortized discount and deferred financing costs	(2)		(2)
2029 Notes (1.125% Convertible Senior Notes)	575		575
Unamortized deferred financing costs	(11)		(12)
Total debt	$	1,087	$	1,104

Credit Facility

As of March 31, 2025, letters of credit totaling $465 million were outstanding under our $2.2 billion credit facility, which matures in February 2028. This credit facility contains customary financial covenants, including a debt-to-capitalization ratio that cannot exceed 0.60 to 1.00, a limitation on the aggregate amount of debt of the greater of $750 million or €750 million for our subsidiaries, and a minimum liquidity threshold of $1.2 billion, all as defined in the amended credit facility, which may be reduced to $1.0 billion upon the repayment of debt. The credit facility also contains provisions that will require us to provide collateral to secure the facility should we be downgraded to BB by S&P and Ba2 by Moody's, such collateral consisting broadly of our U.S. assets. Borrowings under the facility, which may be denominated in USD, EUR or GBP, bear interest at a base rate, plus an applicable borrowing margin. As of March 31, 2025, we had not made any borrowings under our credit facility line and maintained a borrowing capacity of $856 million.

Uncommitted Lines of Credit

As of March 31, 2025, letters of credit totaling $941 million were outstanding under uncommitted lines of credit.

Redemption of 2028 Notes

During the 2025 and 2024 Quarters, we redeemed $18 million and $10 million, respectively, of the aggregate outstanding 2028 Notes, with an immaterial impact on earnings in both periods.

Table of Contents

FLUOR CORPORATION

NOTES TO FINANCIAL STATEMENTS

UNAUDITED

12. Fair Value Measurements

The following table delineates assets and liabilities that are measured at fair value on a recurring basis:


	March 31, 2025								December 31, 2024
	Fair Value Hierarchy								Fair Value Hierarchy
(in millions)	Total		Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3
Assets:
Investment in NuScale(1)	$	1,790	$	1,790	$	—	$	—	$	2,266	$	2,266	$	—	$	—
Trading securities(2)	4		4		—		—		18		18		—		—

_________________________________________________________

(1) We recognize the fair value of our investment in NuScale on a mark-to-market basis based upon the prevailing price of their stock on our balance sheet dates, which resulted in a pre-tax loss of $477 million for the 2025 Quarter. Our investment in NuScale consists of ownership units in NuScale’s operating subsidiary coupled with non-economic voting shares of NuScale. We have the right to collectively exchange these interests for registered and publicly-traded shares of NuScale, subject to certain timing restrictions and NuScale management’s discretion around the maximum number of exchangeable shares each period, if any.

(2) Consists of registered money market funds and an equity index fund held in deferred compensation trusts. These investments represent the net asset value at the close of business of the period based on the last trade or official close of an active market or exchange.

The following summarizes information about financial instruments that are not required to be measured at fair value:


		March 31, 2025				December 31, 2024
(in millions)	Fair Value Hierarchy	Carrying Value		Fair Value		Carrying Value		Fair Value
Assets:
Cash(1)	Level 1	$	1,644	$	1,644	$	1,613	$	1,613
Cash equivalents(2)	Level 2	789		789		1,216		1,216
Marketable securities(2)	Level 2	78		78		130		130
Notes receivable, including noncurrent portion(3)	Level 3	9		9		9		9
Liabilities:
2028 Senior Notes(4)	Level 2	$	523	$	501	$	541	$	517
2029 Senior Notes(4)	Level 2	564		611		563		725

_________________________________________________________

(1) Cash consists of bank deposits. Carrying amounts approximate fair value.

(2) Cash equivalents and marketable securities primarily consists of time deposits. Carrying amounts approximate fair value because of the short-term maturity of these instruments. Amortized cost is not materially different from the fair value.

(3) Notes receivable are carried at net realizable value which approximates fair value. Factors considered in determining the fair value include the credit worthiness of the borrower, current interest rates, the term of the note and any collateral pledged as security. Notes receivable are periodically assessed for impairment.

(4) The fair value of the Senior Notes was estimated based on quoted market prices and Level 2 inputs.

Table of Contents

FLUOR CORPORATION

NOTES TO FINANCIAL STATEMENTS

UNAUDITED

13. Stock-Based Compensation

Our executive and director stock-based compensation plans are described more fully in the 2024 10-K.

Equity Awards

Performance-based award units totaling 273,564 and 272,844 were awarded to most officers, including all Section 16 officers, during 2025 and 2024 Quarters, respectively. These awards generally cliff vest after 3 years and contain annual performance conditions for each of the 3 years of the vesting period. Under GAAP, performance-based elements of such awards are not deemed granted until the performance targets have been established. The performance targets for each year are generally established in the first quarter.

For awards granted under the 2025 performance award plan, 70% of the award is earned based on achievement of earnings before taxes targets over three 1-year periods and 30% of the award is earned based on our 3-year cumulative TSR relative to companies in the S&P 500 on the date of the award. For awards granted under the 2024 and 2023 performance award plan, 80% of the award is earned based on achievement of earnings before taxes targets overthree 1-year periods and 20% of the award is earned based on our3-year cumulative TSR relative to companies in the S&P 500 on the date of the award. The performance component of these awards is deemed granted when targets are set while the TSR component of these awards is deemed granted upon issuance. During the 2025 Quarter, the following units were granted based upon the establishment of performance targets:


	Performance-based Award Units Granted in 2025	Weighted Average Grant Date Fair Value Per Share
2025 Performance Award Plan	145,904	$37.12
2024 Performance Award Plan	72,756	$39.75
2023 Performance Award Plan	73,271	$39.75

For awards granted under these performance award plans, the number of units are adjusted at the end of each performance period based on attainment of certain performance targets and on market conditions, pursuant to the terms of the award agreements. As of March 31, 2025, there were 200,416 shares associated with performance awards that had been awarded to employees, but which are not deemed granted due to the underlying performance targets having not yet been established.

Liability Awards

SGI awards granted to executives vest and become payable at a rate of 1/3 of the total award each year. Performance-based awards were awarded to non-Section 16 executives and will be settled in cash.


	Location in Statement of Operations	3ME March 31,
(in millions)		2025		2024
SGI awards	G&A	$	(3)	$	5
Performance-based awards for non-Section 16 executives	G&A	3		8


Liabilities (in millions)	Location on Balance Sheet	March 31, 2025		December 31, 2024
SGI awards	Accrued salaries, wages and benefits and other noncurrent liabilities	$	26	$	51
Performance-based awards for non-Section 16 executives	Accrued salaries, wages and benefits and other noncurrent liabilities	24		30

Table of Contents

FLUOR CORPORATION

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with our financial statements and our 2024 10-K. Except as the context otherwise requires, the terms Fluor or the Registrant, as used herein, are references to Fluor and references to the company, we, us, or our, as used herein, shall include Fluor, its consolidated subsidiaries and joint ventures.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Certain statements made herein, including statements regarding our projected operating results, liquidity, capital allocation plans, backlog levels and the implementation of strategic initiatives are forward-looking in nature. Under the Private Securities Litigation Reform Act of 1995, a “safe harbor” may be provided to us for certain of these forward-looking statements. We caution readers that forward-looking statements, including disclosures which use words such as we “believe,” “anticipate,” “expect,” “estimate,” "aspire," "commit," "will," "may" and similar statements, are subject to risks and uncertainties which could cause actual results to differ materially from stated expectations. Significant factors potentially contributing to such differences include:

•The cyclical nature of many of the markets we serve and our clients' vulnerability to poor economic conditions, such as inflation, slow growth or recessions, which may result in decreased capital investment and reduced demand for our services;

•Our failure to receive anticipated new contract awards and the related impact on our operations;

•Failure to accurately estimate the cost and schedule on our projects, potentially resulting in cost overruns or obligations, including those related to project delays and those caused by the performance of our clients, subcontractors, suppliers and partners;

•Intense competition in the global EPC industry, which can place downward pressure on our contract prices and profit margins and may increase our contractual risks;

•The inability to hire and retain qualified personnel;

•Failure of our joint venture partners to perform their venture obligations, which could impact the success of those ventures and impose additional financial and performance obligations on us;

•Failure of our suppliers or subcontractors to provide supplies or services at the agreed-upon levels or times;

•Cybersecurity breaches of our systems and information technology;

•Exposure to political and economic risks in different countries, including tariffs and trade policies, geopolitical events and conflicts, civil unrest, security issues, labor conditions and other unforeseeable events in the countries in which we do business;

•Project cancellations, scope adjustments or deferrals, or foreign currency fluctuations, that could reduce the amount of our backlog and the revenue and profits that we earn;

•Repercussions of events beyond our control, such as severe weather conditions, natural disasters, pandemics, political crises or other catastrophic events, that may significantly affect operations, result in higher cost or subject the company to contract claims by our clients;

•Differences between our actual results and the assumptions and estimates used to prepare our financial statements;

•Earnings volatility due to recurring fair value measurements of our investment in NuScale;

•Client delays or defaults in making payments;

•The potential impact of changes in tax laws and other tax matters including, but not limited to, those from foreign operations, the realizability of our deferred tax assets and the ongoing audits by tax authorities;

•Our ability to secure appropriate insurance;

•The loss of business from one or more significant clients;

•The inability to adequately protect our intellectual property rights;

•The availability of credit and financial assurances plus restrictions imposed by credit facilities, both for us and our clients, suppliers, subcontractors or other partners;

•Adverse results in existing or future litigation, regulatory proceedings or dispute resolution proceedings (including claims for indemnification), or claims against project owners, subcontractors or suppliers;

•Failure of our employees, agents or partners to comply with laws, which could result in harm to our reputation and reduced profits or losses;

•The impact of new or changing legal requirements, as well as past and future environmental, health and safety regulations including climate change regulations; and

•The risks associated with our strategic initiatives, including dispositions.

Any forward-looking statements that we may make are based on our current expectations and beliefs concerning future developments and their potential effects on us. There is no assurance that future developments affecting us will be those presently anticipated by us.

Additional information concerning these and other factors can be found in our press releases and periodic filings with the SEC, including the 2024 10-K. These filings are available publicly on the SEC’s website at http://www.sec.gov, on our website at http://investor.fluor.com or upon request from our Investor Relations Department at (469) 398-7222. We cannot control such risk factors and other uncertainties, and in many cases, cannot predict the risks and uncertainties that could cause actual results to differ materially from those indicated by the forward-looking statements. These risks and uncertainties should be considered when evaluating Fluor and deciding whether to invest in our securities. Except as otherwise required by law, we undertake no obligation to publicly update or revise our forward-looking statements, whether as a result of new information, future events or otherwise.

Results of Operations

In the 2025 Quarter, we completed the sale of Stork's U.K. operations. The sale did not have a material impact on the financial statements. In the 2024 Quarter, we completed the sale of Stork's operations in continental Europe for $67 million and recognized a gain on sale of $11 million including de-recognition of Stork's net assets and cumulative foreign currency translation. After completing the wind down of the Trinidad and Tobago operations later this year, Stork's divestiture will be complete.

We recognize the fair value of our investment in NuScale on a mark-to-market basis based upon the prevailing price of their stock on our balance sheet dates, which resulted in a pre-tax loss of $477 million for the 2025 Quarter. Our investment in NuScale consists of ownership units in NuScale’s operating subsidiary coupled with non-economic voting shares of NuScale. We have the right to collectively exchange these interests for registered and publicly-traded shares of NuScale, subject to certain timing restrictions and NuScale management’s discretion around the maximum number of exchangeable shares each period, if any. Although we use the Level 1 fair value of the publicly-traded shares, the restrictions associated with the conversion could cause the net realizable value of the investment to be different than the implied fair value. NuScale's results for the 2024 Quarter were included in our Other segment as it was prior to our deconsolidation of NuScale.


	3ME March 31,
(in millions)	2025			2024
Revenue
Urban Solutions	$	2,157		$	1,479
Energy Solutions	1,206			1,432
Mission Solutions	597			601
Other	22			222
Total revenue	$	3,982		$	3,734

Segment profit (loss) $ and margin %
Urban Solutions	$	70	3.2%	$	50	3.4%
Energy Solutions	47		3.9%	68		4.7%
Mission Solutions	5		0.8%	22		3.7%
Other	9		40.9%	(22)		NM
Total segment profit $ and margin %(1)	$	131	3.3%	$	118	3.2%

G&A	(36)			(59)
Foreign currency gain (loss)	(13)			12
Interest income (expense), net	17			39
Earnings (loss) attributable to NCI	9			(19)
Earnings before taxes	108			91
Income tax benefit (expense) (including $73 million tax benefit attributable to equity method loss in 2025)	53			(51)
Net earnings before equity method earnings	161			40
Equity method earnings (loss)	(393)			—
Net earnings (loss)	(232)			40
Less: Net earnings (loss) attributable to NCI	9			(19)
Net earnings (loss) attributable to Fluor	$	(241)		$	59

New awards
Urban Solutions	$	5,330		$	4,873
Energy Solutions	315			716
Mission Solutions	164			1,145
Other	2			284
Total new awards	$	5,811		$	7,018

New awards related to projects located outside of the U.S.	10%			27%


(in millions)	March 31, 2025		December 31, 2024
Backlog (2)(3)
Urban Solutions	$	20,150	$	17,749
Energy Solutions	6,161		7,605
Mission Solutions	2,397		2,727
Other	10		403
Total backlog	$	28,718	$	28,484

Backlog related to projects located outside of the U.S.	42%		55%
Backlog related to reimbursable projects	79%		79%

(1)Total segment profit and margin are non-GAAP financial measures. We believe that total segment profit provides a meaningful perspective on our results as it is the aggregation of individual segment profit measures that we use to evaluate and manage our performance.

(2)Backlog at March 31, 2025 was level with backlog at December 31, 2024. We booked a multi-billion award for a life sciences project during the 2025 Quarter. However, we also adjusted backlog on 2 large projects due to reductions in scope and the associated CFM. Backlog may include significant estimated amounts of third-party, subcontracted, CFM and pass-through costs. We do not report new awards or backlog for projects related to our equity method investments even though these awards may be significant contributors to earnings in future periods. Although backlog reflects business that is considered to be firm, cancellations, deferrals or scope adjustments may occur.

(3)Includes backlog of $585 million and $702 million for ongoing legacy projects in a loss position as of March 31, 2025 and December 31, 2024, respectively.

Revenue increased during the 2025 Quarter primarily driven by a ramp up of execution activities on several large projects in our Urban Solutions segment partially offset by revenue declines in Energy Solutions.

Earnings before taxes improved in the 2025 Quarter driven by the ramp up of execution activities on Urban Solutions projects discussed above as well as a reduction in G&A for stock-based compensation partially offset by a decline in net interest income and a foreign currency loss.

Net earnings excluding amounts attributable to equity method earnings were as follows:


	3ME
(in millions)	March 31, 2025

Earnings before taxes	$	108

Income tax benefit	53
Less: Income tax benefit attributable to equity method loss	(73)
Income tax expense and effective tax rate, excluding amount attributable to equity method loss	(20)		19	%

Net earnings excluding amount attributable to equity method loss	$	88

Equity method loss	$	(393)
Income tax benefit and effective tax rate attributable to equity method loss	73		19	%
Equity method loss, net of related income tax benefit	$	(320)

Net earnings/(loss)	$	(232)

The effective tax rate on earnings for the 2025 Quarter was (49)% compared to 56% for the 2024 Quarter. A reconciliation of U.S. statutory federal income tax expense to income tax expense follows:


	3ME March 31,
(In millions)	2025		2024
U.S statutory federal income tax (benefit) expense	$	(60)	$	19
Increase (decrease) in taxes resulting from:
State and local income taxes, net of federal income tax effects	(7)		1
Valuation allowance, net	2		(4)
Foreign tax impacts	7		7
Noncontrolling interest	(2)		4
Reserve for uncertain tax positions	(3)		17
Other adjustments	10		7
Total income tax (benefit) expense	$	(53)	$	51

Beginning in January 2024, many non-US tax jurisdictions have enacted or are in the process of enacting legislation to adopt a minimum effective tax rate described in the Global Anti-Base Erosion Model Rules, also known as Pillar Two. Pillar Two establishes a global minimum tax of 15% on large multinational corporations. We considered the applicable tax law changes in the countries in which we operate and have determined that there is no material impact to our tax provision for the 2025 Quarter. We will continue to evaluate the impact of these tax law changes on future periods.

Our profit margin percentages may be favorably or unfavorably impacted by a change in the amount of CFM recorded. We record revenue on a gross basis, including CFM when we have concluded that we are a principal with respect to such materials and services, though the timing of CFM receipt can significantly impact completion percentage.

Segment Operations

Urban Solutions

Revenue significantly increased in the 2025 Quarter due to the ramp up of execution activities on life sciences projects awarded in the last 18 months as well as revenue growth on a large metals project and a large mining project. The increase in 2025 revenue was further driven by progression to completion on a metals project in which there was a change in scope and removal of CFM.

Segment profit increased in the 2025 Quarter due to an increase in execution activities on life sciences projects awarded in the last 18 months and a large metals project as well as a decrease in cost due to design optimization on a highway project. We also recognized profit on a metals project upon a change in percentage of completion due to a reduction in scope. The increase in segment profit was partially offset by the effects of unfavorable foreign currency movements on an international bridge project. Segment profit margin in the 2025 Quarter was consistent with the 2024 Quarter.

New awards increased during the 2025 Quarter due to a large EPC award for a second multi-billion dollar pharmaceutical facility in Indiana and a construction contract for State Highway 6 in Texas. Backlog increased during the 2025 Quarter due to these 2 large awards. Our staffing business does not report new awards or backlog.

Energy Solutions

Revenue decreased during the 2025 Quarter due to a decline in execution activity for several projects nearing completion partially offset by the ramp up of execution activities on a chemicals project in Canada and a batteries project in Poland.

Segment profit and profit margin declined during the 2025 Quarter due to projects nearing completion and the impact of reserves taken for a joint venture project in Mexico completed in 2019, partially offset by profit recognition on a chemicals project upon a change in percentage of completion due to a client directed change in scope. Segment profit and segment profit margin in the 2024 Quarter was adversely impacted by $29 million in cost growth on a construction only subcontract executed by our joint venture in Mexico.

New awards declined during the 2025 Quarter compared to the 2024 Quarter. Backlog declined during the 2025 Quarter due to the execution pace exceeding new award activity.

Mission Solutions

Revenue in the 2025 Quarter was level with revenue in the 2024 Quarter. Revenue growth due to increased volume on a DOE project and FEMA hurricane relief efforts was offset by revenue declines resulting from reduced volume on a different DOE project and the recognition of an additional reserve resulting from a recent ruling on a long-standing claim on a project completed in 2019.

Segment profit and profit margin declined during the 2025 Quarter compared to the 2024 Quarter due to an additional reserve of $28 million resulting from a recent ruling on a long-standing claim on a project completed in 2019 partially offset by volume-related growth on a DOE project.

New awards declined during the 2025 Quarter compared to the 2024 Quarter. Backlog included $369 million and $665 million of unfunded government contracts as of March 31, 2025 and December 31, 2024, respectively. Unfunded backlog reflects our estimate of future revenue under awarded government contracts for which funding has not yet been appropriated. We do not report new awards or backlog for projects related to our equity method investments even though these awards may be significant contributors to earnings in future periods.

Other

NuScale's results for the 2024 Quarter were included in our Other segment as it was prior to our deconsolidation of NuScale in October 2024. In the 2025 Quarter, we completed the sale of Stork's operations in the U.K. and recognized a gain on sale of $7 million compared to an $11 million gain on the sale of Stork's operations in continental Europe in the 2024 Quarter. We expect results from our Other segment to be immaterial for 2025.

G&A


	3ME March 31,
(in millions)	2025		2024
G&A
Compensation	$	24	$	43
Legal & professional fees	3		3
Exit costs	2		5
Facilities	—		2
Other	7		6
G&A	$	36	$	59

The decrease in compensation expense in the 2025 Quarter was primarily driven by lower stock-based compensation, largely resulting from a decrease in our stock price and corresponding TSR metrics between December 31, 2024 and March 31, 2025.

Critical Accounting Policies and Estimates

There have been no material changes in our critical accounting policies and estimates from those disclosed in our 2024 10-K.

Recent Accounting Pronouncements

Item is described more fully in the Notes to Financial Statements.

Table of Contents

LIQUIDITY AND CAPITAL RESOURCES

Our liquidity arises from available cash and cash equivalents and marketable securities, cash generated from

operations, capacity under our credit facility and, when necessary, access to capital markets. We have committed and uncommitted lines of credit available for revolving loans and letters of credit. We believe that for at least the next 12 months, anticipated cash generated from operations, along with our unused credit capacity and cash position, is sufficient to support operating requirements and debt maturities. We regularly review our sources and uses of liquidity and may pursue opportunities to address our liquidity needs that arise.

Our credit facility contains provisions that will require us to provide collateral to secure the facility should we be downgraded to BB by S&P and Ba2 by Moody's, which is a one notch downgrade from both agencies' current ratings. If we are required to provide collateral, it would consist broadly of liens on our U.S. assets.

As of March 31, 2025, letters of credit totaling $465 million were outstanding under our $2.2 billion credit facility, which matures in February 2028. This credit facility contains customary financial covenants, including a debt-to-capitalization ratio that cannot exceed 0.60 to 1.00, based upon total shareholders' equity excluding AOCI, a limitation on the aggregate amount of debt of the greater of $750 million or €750 million for our subsidiaries, and a minimum liquidity threshold of $1.2 billion, all as defined in the amended credit facility, which may be reduced to $1.0 billion upon the repayment of debt. Borrowings under the facility, which may be denominated in USD, EUR or GBP, bear interest at a base rate, plus an applicable borrowing margin. As of March 31, 2025 and through the issuance of this 10-Q, we had not made any borrowings under our credit facility. We have a sublimit of up to $1.0 billion in aggregate cash advances and financial letters of credit available to us under our credit facility with a current borrowing capacity of $856 million.

Cash and cash equivalents combined with marketable securities were $2.5 billion and $3.0 billion as of March 31, 2025 and December 31, 2024, respectively. Cash and cash equivalents are held in numerous accounts throughout the world to fund our global project execution activities. Non-U.S. cash and cash equivalents amounted to $1.1 billion as of both March 31, 2025 and December 31, 2024. Non-U.S. cash and cash equivalents exclude deposits of U.S. legal entities that are invested in offshore, overnight accounts or short-term time deposits, to which there is unrestricted access.

In evaluating our liquidity needs, we consider cash and cash equivalents held by our consolidated variable interest entities (joint ventures and partnerships). These amounts (which totaled $325 million and $333 million as of March 31, 2025 and December 31, 2024, respectively) were not necessarily readily available for general purposes. We do not include our share of cash held by our proportionately consolidated joint ventures and partnerships in our consolidated cash balances even though these amounts may be significant. We also consider the extent to which client advances (which totaled $48 million and $79 million as of March 31, 2025 and December 31, 2024, respectively) are likely to be sustained or consumed over the near term for project execution activities and the cash flow requirements of our various foreign operations. In some cases, it may not be financially efficient to move cash and cash equivalents between countries due to statutory dividend limitations and/or adverse tax consequences. We did not consider any cash to be permanently reinvested outside the U.S. as of March 31, 2025 and December 31, 2024, other than unremitted earnings required to meet our working capital and long-term investment needs in non-U.S. foreign jurisdictions where we operate.

In the 2025 Quarter, we used $142 million to repurchase and cancel 3,576,745 shares of common stock under our repurchase program. Over 24,000,000 shares could still be purchased under the repurchase program as of March 31, 2025. Between April 1, 2025 and April 25, 2025, we repurchased and canceled approximately 1.5 million shares of our common stock for $51 million. We expect to repurchase approximately $150 million of our stock during the second quarter of 2025 and approximately $300 million of our stock during the latter half of 2025.

Table of Contents

Cash Flows


	3ME March 31,
(in millions)	2025		2024
OPERATING CASH FLOW	$	(286)	$	(111)

INVESTING CASH FLOW
Proceeds from sales and maturities (purchases) of marketable securities	54		(5)
Capital expenditures	(11)		(34)
Proceeds from sale of assets	62		30
Investments in partnerships and joint ventures	(69)		(13)

Investing cash flow	36		(22)

FINANCING CASH FLOW
Repurchase of common stock	(142)		—
Purchase and retirement of debt	(18)		(10)
Other	(3)		(16)
Financing cash flow	(163)		(26)

Effect of exchange rate changes on cash	17		(25)
Increase (decrease) in cash and cash equivalents	(396)		(184)
Cash and cash equivalents at beginning of period	2,829		2,519
Cash and cash equivalents at end of period	$	2,433	$	2,335

Cash paid during the period for:
Interest	$	19	$	20
Income taxes (net of refunds)	30		46

Operating Activities

Cash flows from operating activities result primarily from our core EPC activities and are affected by our earnings level and changes in working capital associated with such activities. Working capital levels vary from period to period and are primarily affected by our volume of work and billing schedules on our projects. These levels are also impacted by the stage of completion and commercial terms of engineering and construction projects, as well as our execution of our projects compared to their budget. Working capital requirements also vary by project and the payments terms agreed to with our clients, vendors and subcontractors. Most contracts require payments as the projects progress. Additionally, certain projects receive advance payments from clients. A typical trend for our lump-sum projects is to have higher cash balances during the initial phases of execution due to deposits paid to us which then diminish toward the end of the construction phase. As a result, our cash position is reduced as customer advances are utilized, unless they are replaced by advances on other projects. We maintain cash reserves and borrowing facilities to provide additional working capital in the event that a project’s net operating cash outflows exceed its available cash balances. As of March 31, 2025, our backlog included $585 million for ongoing legacy projects in a loss position, including approximately $189 million of estimated unfunded losses associated therewith. The comparable amounts at December 31, 2024 were $702 million of backlog and $237 million of unfunded losses.

Our operating cash flow is typically lower in the first quarter of each year due to the timing of payout of employee incentive awards from the prior year. Our operating cash flow for the 2025 and 2024 Quarters was also negatively impacted by increases in working capital on several large projects.

Table of Contents

Investing Activities

We hold cash in bank deposits and marketable securities which are governed by our investment policy. This policy focuses on, in order of priority, the preservation of capital, maintenance of liquidity and maximization of yield. These investments may include money market funds, bank deposits placed with highly-rated financial institutions, repurchase agreements that are fully collateralized by U.S. Government-related securities, high-grade commercial paper and high quality short-term and medium-term fixed income securities.

Capital expenditures in 2025 primarily related to investments in IT compared to expenditures for improvements to our new office lease in Houston as well as construction equipment on infrastructure projects in 2024.

Net proceeds from sales of assets during the 2025 Quarter included $61 million from the sale of Stork's U.K. operations compared to $29 million from the sale of Stork's European business in the 2024 Quarter. We received additional proceeds of $38 million from the sale of Stork Europe in April 2024.

Investments in unconsolidated partnerships and joint ventures in the 2025 Quarter included $55 million in funding on a loss project for an infrastructure joint venture.

Financing Activities

We have a stock repurchase program, authorized by our Board of Directors, to purchase shares in the open market or privately negotiated transactions at our discretion. In November 2024, the Board authorized an additional 20,000,000 shares to the repurchase program. During 2025 Quarter, we repurchased 3,576,745 shares of common stock under the repurchase program for total consideration of $142 million. As of March 31, 2025, over 24,000,000 shares could still be purchased under the repurchase program.

During the 2025 and 2024 Quarters, we redeemed $18 million and $10 million, respectively, of the aggregate outstanding 2028 Notes, with an immaterial impact on earnings in both periods.

Letters of Credit

As of March 31, 2025, letters of credit totaling $465 million were outstanding under committed lines of credit. As of March 31, 2025, letters of credit totaling $941 million were outstanding under uncommitted lines of credit including letters of credit totaling $344 million for two lump-sum projects in Kuwait that are substantially complete except for the resolution of unapproved change orders and extension of time claims. Letters of credit are ordinarily provided to indemnify our clients if we fail to perform our obligations under our contracts. Surety bonds may be used as an alternative to letters of credit.

Guarantees

Financial guarantees, made in the ordinary course of business in certain limited circumstances, are entered into with financial institutions and other credit grantors and generally obligate us to make payment in the event of a default by the borrower. These arrangements generally require the borrower to pledge collateral to support the fulfillment of the borrower’s obligation.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

There have been no material changes to market risk during 2025 Quarter. Accordingly, our disclosures provided in the 2024 10-K remain relevant.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Based on their evaluation as of the end of the period covered by this report, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) of the Exchange Act) are effective as required by paragraph (b) of Rule 13a-15 or Rule 15d-15 of the Exchange Act.

Table of Contents

Changes in Internal Control over Financial Reporting

There were no changes to our ICFR that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our ICFR.

Table of Contents

FLUOR CORPORATION

CHANGES IN CONSOLIDATED BACKLOG

UNAUDITED


	3ME March 31,
(in millions)	2025		2024
Backlog, January 1	$	28,484	$	29,441
New awards	5,811		7,018
Adjustments and cancellations, net	(1,619)		(20)
Work performed	(3,958)		(3,700)
Backlog, March 31	$	28,718	$	32,739

Table of Contents

PART II: OTHER INFORMATION

Item 1. Legal Proceedings

As part of our normal business activities, we are party to a number of legal proceedings and other matters in various stages of development. Management periodically assesses our liabilities and contingencies in connection with these matters based upon the latest information available. We disclose material pending legal proceedings pursuant to SEC rules and other pending matters as we may determine to be appropriate.

Additional information on matters in dispute may be found in Part I, Item 1 of this Q1 2025 10-Q.

Item 1A. Risk Factors

There have been no material changes from our risk factors as disclosed in the 2024 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(c) The following table provides information for the quarter ended March 31, 2025 about purchases by the company of equity securities that have been registered pursuant to Section 12 of the Exchange Act.

Issuer Purchases of Equity Securities


Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Program (1)
January 1 — January 31, 2025	494,574	$	49.92	494,574	27,665,239
February 1 — February 28, 2025	583,904	42.74		583,904	27,081,335
March 1 — March 31, 2025	2,498,267	36.87		2,498,267	24,583,068
Total	3,576,745	$	39.63	3,576,745

_________________________________________________________

(1) The share repurchase program was originally announced on November 3, 2011 and, as amended, totaled 66,000,000 shares as of March 31, 2025, including 20,000,000 shares incrementally authorized by the Board in November 2024. We may repurchase shares from time to time in open market or privately negotiated transactions, including through pre-arranged trading programs, at our discretion, subject to market conditions and other factors and at such time and in amounts that we deem appropriate. The share repurchase program has no fixed expiration date.

Item 4. Mine Safety Disclosures

Information concerning mine safety violations or other regulatory matters required by Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K (17 CFR 229.104) is included in Exhibit 95.1 to this report.

Item 5. Other Information

During the quarter ended March 31, 2025, no director or officer (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408(a) of Regulation S-K).

Table of Contents

Item 6. Exhibits

EXHIBIT INDEX


Exhibit						Description
3.1						Amended and Restated Certificate of Incorporation of the registrant (incorporated by reference to Exhibit 3.1 to the registrant's Current Report on Form 8-K (Commission file number 1-16129) filed on May 8, 2012).
3.2						Amended and Restated Bylaws of the registrant (incorporated by reference to Exhibit 3.1 to the registrant's Current Report on Form 8-K (Commission file number 1-16129) filed on November 4, 2022).
10.1						$2 ,2 00,000 Fourth Amended and Restated Revolving Loan and Letter of Credit Facility Agreement dated as of February 1 4 , 202 5 , among Fluor Corporation, the Lenders thereunder, BNP Paribas, as Administrative Agent and an Issuing Lender, Bank of America, N.A., as Syndication Agent, and Citibank, N.A. and Wells Fargo Bank, National Association, as Co-Documentation Agents .*
31.1						Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2						Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1						Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
32.2						Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
95.1						Mine Safe ty Disclosure.*
101.INS						Inline XBRL Instance Document.*
101.SCH						Inline XBRL Taxonomy Extension Schema Document.*
101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.LAB						Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase Document.*
104						The cover page from the Company's Q1 2025 10-Q for the three months ended March 31, 2025, formatted in Inline XBRL (included in the Exhibit 101 attachments).*

_______________________________________________________________________

* New exhibit filed with this report.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


			FLUOR CORPORATION


Date:	May 1, 2025	By:	/s/ John C. Regan
			John C. Regan
			Chief Financial Officer
			(Principal Financial & Accounting Officer)